Tekla Life Profile

USD 0.04  0.20%

Purchase by Kent Thomas M of 1300 shares of Tekla Life

Tekla Life Sciences Investors insider trading alert for perchase of shares of beneficial interest by Kent Thomas M, the corporate stakeholder, on January 29, 2018. This event was filed by Tekla Life Sciences Inves with SEC on 2018-01-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Tekla Life Summary

Tekla Life Sciences Investors (HQL) is traded on New York Stock Exchange in USA. It is located in 2 Liberty Square and employs 13 people. The company currently falls under 'Small-Cap' category with total capitalization of 450.73 M. Tekla Life Sciences Investors has 21.17 M outstanding shares of which 76.57 K shares are currently shorted by investors with about 0.0 days to cover shorted positions. HQ LIFE SCIENCES has about 615.31 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Tekla Life Probability Of Bankruptcy

Ownership Allocation (%)

Tekla Life Target Price Odds Analysis

Odds Below 19.8HorizonTargetOdds Above 19.8
30.64%30 days 19.80 68.77%
Based on normal probability distribution, the odds of Tekla Life to move above current price in 30 days from now is about 68.77% (This Tekla Life Sciences Investors probability density function shows the probability of Tekla Life Stock to fall within a particular range of prices over 30 days) .

Tekla Life Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Morgan StanleyFund Units621.9 K11.7 M
View Tekla Life Diagnostics

Tekla Life Sciences Risk Profiles

Tekla Life Key Fundamentals

Tekla Life Against Markets

Tekla Life Current Ratings

Tekla Life Sciences Investors 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Tekla Life Sciences Investors are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Closed-End Fund - Equity classification in USA and traded on New York Stock Exchange. more
NameTekla Life Sciences Investors
PresidentDaniel OmsteadView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address2 Liberty Square
ExchangeNew York Stock Exchange
Phone617 772 8500
CurrencyUSD - US Dollar

Current Sentiment - HQL

Tekla Life Sciences Investor Sentiment

Greater number of Macroaxis users are currently bullish on Tekla Life Sciences Investors. What is your outlook on investing in Tekla Life Sciences Investors? Are you bullish or bearish?
98% Bullish
2% Bearish


Tekla Life Corporate Management

William Reardon Independent Trustee
Michael Bonney Independent Trustee
Oleg Pohotsky Independent Trustee
Lucinda Stebbins Independent Trustee
Uwe Reinhardt Independent Trustee
Rakesh Jain Independent Trustee
Please also check Risk vs Return Analysis. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Search macroaxis.com